North America Medical Clinical Nutrition Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers North America Clinical Nutrition Companies and it is Segmented by Route of Administration (Oral and Enteral, Parenteral), Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Neurological Diseases, Cancer, Other Indications), End-User (Pediatric and Adult), and Geography (United States, Canada, and Mexico). The report offers the value (in USD million) for the above segments.

North America Medical Clinical Nutrition Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

North America Medical Clinical Nutrition Market Size

View Global Report
North America Clinical Nutrition Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 31.73 Billion
Market Size (2030) USD 42.84 Billion
CAGR (2025 - 2030) 6.19 %

Major Players

North America Clinical Nutrition Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of North America Clinical Nutrition Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

North America Medical Clinical Nutrition Market Analysis

The North America Clinical Nutrition Market size is estimated at USD 31.73 billion in 2025, and is expected to reach USD 42.84 billion by 2030, at a CAGR of 6.19% during the forecast period (2025-2030).

COVID-19 has significantly impacted the growth of the clinical nutrition market in North America. The increasing risks associated with COVID-19 led to more consumption of clinical nutrition. The research studies conducted to demonstrate the effectiveness of clinical nutrition are also expected to drive the growth of the market studied. For instance, the article 'The Central Role of Clinical Nutrition in COVID-19 Patients During and After Hospitalization in Intensive Care Unit' published in July 2020, suggested that proper evidence-based nutritional therapy was reported for patients with critical COVID-19 conditions and recommended to be included in life-saving therapies. Thus, COVID-19 has impacted market growth during the pandemic.

Certain factors that are propelling the market growth are the increasing prevalence of metabolic disorders, rising spending on healthcare by government and private foundations, and the rising aging population in North American countries.

The growing burden of metabolic disorders is the key factor driving the market growth. For instance, according to statistics published by the International Diabetes Federation, in the 10th edition of 2021, 2,974.0 thousand people were living with diabetes in 2021 in Canada. In addition, as per the same source, this number is projected to reach 3,288.2 thousand by 2030 and 3,468.5 thousand by 2045. Therefore, high blood sugar caused by diabetes can damage the nerves that control the heart and blood vessels, leading to a variety of cardiovascular diseases like coronary artery disease and stroke. This is expected to increase the demand for clinical nutrition to maintain their glucose level, thereby bolstering the market growth.

Additionally, obesity in the Mexican population is found to be the most prevalent heart disease risk factor which is also contributing to the growth of the studied market over the forecast period. For instance, according to 2022 statistics published by World Obesity Federation, it has been observed that 31.5% of men and 40.2% of women are living with obesity in Mexico in 2020. Thus, the growing cases of metabolic disorders among the population in the region are contributing to the market growth over the forecast period.

Furthermore, the growing geriatric population is more prone to develop metabolic disorders due to multiple age-related physiologic mechanisms which are expected to increase the demand for clinical nutrition, thereby propelling the market growth. For instance, according to the 2022 statistics published by the United Nations Population Fund, in Canada, a large proportion of the living population is aged 15-64 and accounts for 65% in 2022. In addition, as per the same source, 19% of the population is aged 65 years and above in 2022. This is expected to boost market growth over the forecast period. The geriatric population shows more vulnerability to diseases that require clinical nutrition, thereby propelling market growth over the forecast period.

However, the imprecise perception of clinical nutrition and the reduction in birth rates are some of the factors that are restraining the market growth over the forecast period.

North America Medical Clinical Nutrition Industry Overview

The North America clinical nutrition market is consolidated with the presence of several international major players, as well as domestic companies in the United States, Canada, and Mexico, which creates a good competitive scenario for companies in the North American clinical nutrition market. Some of the major companies having a good presence across the North American region include Abbott, Nestle, Baxter, B Braun, Danone Nutricia, and Pfizer.

North America Medical Clinical Nutrition Market Leaders

  1. Abbott Laboratories (Abbott Nutrition)

  2. Nestlé SA

  3. Baxter

  4. B. Braun Melsungen AG

  5. Danone Nutricia

  6. *Disclaimer: Major Players sorted in no particular order
North America Clinical nutrition Market - cl.png
Need More Details on Market Players and Competiters?
Download PDF

North America Medical Clinical Nutrition Market News

  • In April 2022, Abbott released limited quantities of metabolic nutrition formulas for infants in the market after the approval of the United States Food and Drug Administration.
  • In January 2022, Guardion Health Sciences, Inc launched a new branded Shopify store to promote and raise the selling of its Viactiv line of products.

North America Medical Clinical Nutrition Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Metabolic Disorders
    • 4.2.2 High Healthcare Spending by Government and Private Foundations
    • 4.2.3 Growing Aging Population in North American Countries
  • 4.3 Market Restraints
    • 4.3.1 Imprecise Perception about Clinical Nutrition
    • 4.3.2 Reduction in Birth Rates
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Route of Administration
    • 5.1.1 Oral and Enteral
    • 5.1.2 Parenteral
  • 5.2 By Application
    • 5.2.1 Nutritional Support for Malnutrition
    • 5.2.2 Nutritional Support for Metabolic Disorders
    • 5.2.3 Nutritional Support for Gastrointestinal Diseases
    • 5.2.4 Nutritional Support for Neurological Diseases
    • 5.2.5 Nutritional Support in Cancer
    • 5.2.6 Nutritional Support in Other Indications
  • 5.3 By End User
    • 5.3.1 Pediatric
    • 5.3.2 Adult
  • 5.4 Geography
    • 5.4.1 United States
    • 5.4.2 Canada
    • 5.4.3 Mexico

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Nutrition
    • 6.1.2 B. Braun Melsungen AG
    • 6.1.3 BASF SE
    • 6.1.4 Baxter Healthcare
    • 6.1.5 Nestle Health Science
    • 6.1.6 Danone S.A. (Nutricia)
    • 6.1.7 Fresenius Kabi
    • 6.1.8 Perrigo Company PLC
    • 6.1.9 Reckitt Benckiser
    • 6.1.10 Baxter
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

North America Medical Clinical Nutrition Industry Segmentation

As per the scope of the report, clinical nutrition products are useful in maintaining the patient's health and enable the improvement of the body's metabolic system by providing adequate supplements, such as minerals, vitamins, and other supplements. A higher number of premature births also demand advanced clinical nutrition. The North America Clinical Nutrition Market is Segmented by Route of Administration (Oral and Enteral, Parenteral), Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Neurological Diseases, Cancer, Other Indications), End-User (Pediatric and Adult), and Geography (United States, Canada, and Mexico). The report offers the value (in USD million) for the above segments.

By Route of Administration Oral and Enteral
Parenteral
By Application Nutritional Support for Malnutrition
Nutritional Support for Metabolic Disorders
Nutritional Support for Gastrointestinal Diseases
Nutritional Support for Neurological Diseases
Nutritional Support in Cancer
Nutritional Support in Other Indications
By End User Pediatric
Adult
Geography United States
Canada
Mexico
Need A Different Region or Segment?
Customize Now

North America Medical Clinical Nutrition Market Research FAQs

How big is the North America Clinical Nutrition Market?

The North America Clinical Nutrition Market size is expected to reach USD 31.73 billion in 2025 and grow at a CAGR of 6.19% to reach USD 42.84 billion by 2030.

What is the current North America Clinical Nutrition Market size?

In 2025, the North America Clinical Nutrition Market size is expected to reach USD 31.73 billion.

Who are the key players in North America Clinical Nutrition Market?

Abbott Laboratories (Abbott Nutrition), Nestlé SA, Baxter, B. Braun Melsungen AG and Danone Nutricia are the major companies operating in the North America Clinical Nutrition Market.

What years does this North America Clinical Nutrition Market cover, and what was the market size in 2024?

In 2024, the North America Clinical Nutrition Market size was estimated at USD 29.77 billion. The report covers the North America Clinical Nutrition Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the North America Clinical Nutrition Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

North America Medical Clinical Nutrition Industry Report

Statistics for the 2025 North America Clinical Nutrition market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Clinical Nutrition analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.